Consistently, ICAM-1 inhibition markedly attenuates macrophage homing to atherosclerotic plaques in ApoE-deficient mice60, which suggests ICAM-1 may play a leading role in atherosclerosis procession. Here, ICAM1 is linked to atherosclerosis.